🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective, randomized, multicenter, parallel, placebo-controlle...
Status
Terminated
Location
Clínica Senhor do Bomfim Ltda
Start Date
2013-12
Trial ID
NCT01695759
Treatments Being Tested
Rationale: The investigators hypothesize that EPO protects against apoptos...
Status
Unknown
Location
Clinical Research Centre Nijmegen
Start Date
2010-07
Trial ID
NCT00691613
Treatments Being Tested
Patients who are admitted to subacute rehabilitation facilities following h...
Status
Terminated
Location
Elms of Cranbury
Start Date
2005-11
Trial ID
NCT00511901
Treatments Being Tested
To establish the efficacy and Safety of rHu-EPO-alpha in patients with anem...
Status
Completed
Location
Dr. Shishir Gang
Start Date
2006-12
Trial ID
NCT00399269
Treatments Being Tested
Neonatal anemia is the most commonly encountered hematologic problem among ...
Status
Completed
Location
University of Iowa Hospitals and Clinics
Start Date
2014-06
Trial ID
NCT02075970
Treatments Being Tested
\* Background: Despite extensive use, to the best of our knowledge, no tria...
Status
Completed
Location
Fahd Bin Jassem Dialysis Centre
Start Date
2012-03
Trial ID
NCT02049346
The purpose of this study is to assess whether maintaining hemoglobin (Hb) ...
Status
Completed
Location
Multiple Locations
Start Date
1999-11
Trial ID
NCT00446576
Treatments Being Tested
Prospective, randomized and open label trial Hypothesis * Infusion of int...
Status
Completed
Location
Seoul National University Bundang Hospital
Start Date
2009-11
Trial ID
NCT01538771
Treatments Being Tested
Patients with epithelial ovarian cancer, fallopian tube or peritoneal cance...
Status
Terminated
Location
Department of Gynecology University of Marburg
Start Date
2004-02
Trial ID
NCT00189371
Treatments Being Tested
Daprodustat has demonstrated an ability to effectively raise hemoglobin con...
Status
Terminated
Location
GSK Investigational Site
Start Date
2019-01-10
Trial ID
NCT03446612